Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$5.9 - $6.95 $1.32 Million - $1.55 Million
223,140 Added 21.63%
1,255,000 $8.27 Million
Q1 2023

May 15, 2023

BUY
$6.18 - $7.99 $349,788 - $452,234
56,600 Added 5.8%
1,031,860 $7.01 Million
Q4 2022

Feb 14, 2023

BUY
$6.87 - $10.96 $247,800 - $395,327
36,070 Added 3.84%
975,260 $7.21 Million
Q3 2022

Nov 14, 2022

BUY
$9.44 - $11.76 $353,622 - $440,529
37,460 Added 4.15%
939,190 $9.28 Million
Q2 2022

Aug 12, 2022

SELL
$9.31 - $11.84 $99,896 - $127,043
-10,730 Reduced 1.18%
901,730 $9.83 Million
Q1 2022

May 13, 2022

BUY
$10.84 - $16.55 $4 Million - $6.1 Million
368,770 Added 67.83%
912,460 $10.3 Million
Q4 2021

Feb 11, 2022

BUY
$15.69 - $21.14 $4.46 Million - $6.01 Million
284,270 Added 109.58%
543,690 $8.53 Million
Q3 2021

Nov 12, 2021

SELL
$15.35 - $21.27 $59,558 - $82,527
-3,880 Reduced 1.47%
259,420 $4.45 Million
Q2 2021

Aug 13, 2021

BUY
$15.71 - $21.51 $322,055 - $440,955
20,500 Added 8.44%
263,300 $5.66 Million
Q1 2021

May 14, 2021

SELL
$13.42 - $20.28 $317,919 - $480,433
-23,690 Reduced 8.89%
242,800 $3.65 Million
Q4 2020

Feb 16, 2021

BUY
$9.77 - $13.81 $2.6 Million - $3.68 Million
266,490 New
266,490 $3.5 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $249M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Hotchkis & Wiley Capital Management LLC Portfolio

Follow Hotchkis & Wiley Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hotchkis & Wiley Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hotchkis & Wiley Capital Management LLC with notifications on news.